Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Wood Website

Lauren V. Wood, M.D.

Selected Publications

1)  Berzofsky JA, Wood LV, Terabe M.
Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.
Expert Rev Vaccines. 12: 1115-8, 2013.
[Journal]
2)  Castiello L, Sabatino M, Zhao Y, Tumaini B, Ren J, Ping J, Wang E, Wood LV, Marincola FM, Puri RK, Stroncek DF.
Quality controls in cellular immunotherapies: rapid assessment of clinical grade dendritic cells by gene expression profiling.
Mol. Ther. 21: 476-84, 2013.
[Journal]
3)  Calabrese SK, Martin S, Wolters PL, Toledo-Tamula MA, Brennan TL, Wood LV.
Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents.
AIDS Care. 24: 1092-6, 2012.
[Journal]
4)  Arlen PM, Wood LV.
Prostate cancer vaccines: moving therapeutic vaccination forward in the post-Provenge era.
Expert Rev Vaccines. 11: 287-302, 2012.
[Journal]
5)  Berzofsky JA, Terabe M, Wood LV.
Strategies to use immune modulators in therapeutic vaccines against cancer.
Semin. Oncol. 39: 348-57, 2012.
[Journal]
6)  Wood LV.
Why I voted "no" to Truvada PrEP.
Ann. Intern. Med. 157: 519-20, 2012.
[Journal]
7)  Martin S, Elliott-DeSorbo DK, Calabrese S, Wolters PL, Roby G, Brennan T, Wood LV.
A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers.
AIDS Patient Care STDS. 23: 593-601, 2009.
[Journal]
8)  Wiener LS, Battles HB, Wood LV.
A longitudinal study of adolescents with perinatally or transfusion acquired HIV infection: sexual knowledge, risk reduction self-efficacy and sexual behavior.
AIDS and behavior. 11: 471-8, 2007.
[Journal]
9)  Martin S, Elliott-DeSorbo DK, Wolters PL, Toledo-Tamula MA, Roby G, Zeichner S, Wood LV.
Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents.
Pediatr. Infect. Dis. J. 26: 61-7, 2007.
[Journal]
10)  Martin S, Wolters PL, Calabrese SK, Toledo-Tamula MA, Wood LV, Roby G, Elliott-Desorbo DK.
The Antiretroviral Regimen Complexity Index: A Novel Method of Quantifying Regimen Complexity.
J Acquir Immune Defic Syndr. 2007.
[Journal]
11)  Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM.
Could human papillomaviruses be spread through blood?.
J. Clin. Microbiol. 43: 5428-34, 2005.
[Journal]
12)  Wiener L, Riekert K, Ryder C, Wood LV.
Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible.
AIDS Patient Care STDS. 18: 527-38, 2004.
[Journal]
13)  Martin SC, Wolters PL, Klaas PA, Perez L, Wood LV.
Coping styles among families of children with HIV infection.
AIDS Care. 16: 283-92, 2004.
[Journal]
14)  Taylor P, Worrell C, Steinberg SM, Hazra R, Jankelevich S, Wood LV, Zwerski S, Yarchoan R, Zeichner S.
Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens.
Pediatrics. 114: e235-42, 2004.
[Journal]
15)  Srivastava S, Taylor P, Wood LV, Lee SS, Robinson MR.
Post-surgical scleritis associated with the ganciclovir implant.
Ophthalmic Surg Lasers Imaging. 35: 254-5, 2004.
[Journal]
16)  Patsalides AD, Wood LV, Atac GK, Sandifer E, Butman JA, Patronas NJ.
Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings.
AJR Am J Roentgenol. 179: 999-1003, 2002.
[Journal]
17)  Chiou CC, Groll AH, Mavrogiorgos N, Wood LV, Walsh TJ.
Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy.
Pediatr Infect Dis J. 21: 388-92, 2002.
[Journal]
18)  Mukhopadhyay A, Wei B, Zullo SJ, Wood LV, Weiner H.
In vitro evidence of inhibition of mitochondrial protease processing by HIV-1 protease inhibitors in yeast: a possible contribution to lipodystrophy syndrome.
Mitochondrion. 1: 511-8, 2002.
[Journal]
19)  Fry TJ, Connick E, Falloon J, Lederman MM, Liewehr DJ, Spritzler J, Steinberg SM, Wood LV, Yarchoan R, Zuckerman J, Landay A, Mackall CL.
A potential role for interleukin-7 in T-cell homeostasis.
Blood. 97: 2983-90, 2001.
[Journal]
20)  Robinson MR, Salit RB, Bryant-Greenwood PK, Zeichner SL, Wood LV, Jaffe ES, van Waes C, Magrath IT.
Burkitt's/Burkitt's-like lymphoma presenting as bacterial sinusitis in two HIV-infected children.
AIDS Patient Care STDS. 15: 453-8, 2001.
[Journal]
21)  Sei S, O'Neill DP, Stewart SK, Yang Q, Kumagai M, Boler AM, Adde MA, Zwerski SL, Wood LV, Venzon DJ, Magrath IT.
Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma.
Cancer Res. 61: 5028-37, 2001.
[Journal]
22)  Jankelevich S, Mueller BU, Mackall CL, Smith S, Zwerski S, Wood LV, Zeichner SL, Serchuck L, Steinberg SM, Nelson RP, Sleasman JW, Nguyen BY, Pizzo PA, Yarchoan R.
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
J Infect Dis. 183: 1116-20, 2001.
[Journal]
23)  Sei S, Boler AM, Nguyen GT, Stewart SK, Yang QE, Edgerly M, Wood LV, Brouwers P, Venzon DJ.
Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.
AIDS. 15: 1343-52, 2001.
[Journal]
24)  Gonzalez CE, Adde M, Taylor P, Wood LV, Magrath I.
Impact of chemotherapy for AIDS-related malignancies in pediatric HIV disease.
Ann N Y Acad Sci. 918: 362-6, 2000.
[Journal]
25)  Miller KD, Cameron M, Wood LV, Dalakas MC, Kovacs JA.
Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases.
Ann Intern Med. 133: 192-6, 2000.
[Journal]
26)  Gonzalez CE, Samakoses R, Boler AM, Hill S, Wood LV.
Lymphoid interstitial pneumonitis in pediatric AIDS. Natural history of the disease.
Ann N Y Acad Sci. 918: 358-61, 2000.
[Journal]
27)  Toro JR, Wood LV, Patel NK, Turner ML.
Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.
Arch Dermatol. 136: 983-5, 2000.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 4/16/2014.